Chiron Real Estate Inc. Raises Up to $100 Million in Delayed-Draw Convertible Preferred Equity Led by Maewyn Capital Partners
May 7, 2026
Chiron Real Estate Inc. (NYSE: XRN) entered into an agreement for up to a $100 million delayed-draw, convertible perpetual preferred equity investment led by Maewyn Capital Partners. The financing is designed to support Chiron’s portfolio repositioning toward higher-return healthcare real estate opportunities, including senior housing, with funds drawn over six months subject to closing conditions.
- Buyers
- Maewyn Capital Partners LLC
- Targets
- Chiron Real Estate Inc.
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Chiron Real Estate Acquires $425M of Senior Housing Communities from Silverstone Affiliates
May 6, 2026
Healthcare Services
Chiron Real Estate Inc. entered into purchase agreements to acquire three seniors housing communities from affiliates of Silverstone Senior Living for an aggregate purchase price of $425 million. The deal includes two Alexandria, Virginia communities (The Landing and The Riviera) expected to close around June 1, 2026, and the Pinnacle North Bethesda in Maryland expected to close around October 2026.
-
QXO Upsizes Convertible Preferred Equity Commitment to $3 Billion
January 12, 2026
Building Products
QXO expanded a previously announced convertible preferred equity financing to a $3 billion commitment, increasing capacity to fund future acquisitions through July 15, 2026. The financing is led by funds managed by affiliates of Apollo Global Management, with Temasek and other investors participating.
-
ChrysCapital Acquires Minority Stake in La Renon
April 16, 2024
Pharmaceuticals
India-focused PE firm ChrysCapital is investing about $70 million to acquire a minority stake in Ahmedabad-based pharmaceutical company La Renon. The growth investment will support La Renon's expansion plans across chronic therapeutic segments, strengthen manufacturing and R&D capabilities, and fund geographic expansion into international markets.
-
Blue Heron Capital Leads $14M Series B Investment in Redi Health
February 28, 2024
Healthcare Services
Blue Heron Capital led a $14 million Series B growth investment in Redi Health, a Columbus-based digital health company that connects pharmaceutical manufacturers, providers, and patients on a unified patient support platform. Participating investors included Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25; Redi will use the funding to accelerate product development, expand its patient network, and scale its patient support services.
-
Ascend Capital Partners and Kain Capital Back Rendr–Excelsior Combination to Form Integrated Medical Group
November 28, 2022
Healthcare Services
Ascend Capital Partners and Kain Capital are backing the combination of Rendr and Excelsior Integrated Medical Group to create a New York City integrated multi-specialty medical group operating under the name Rendr. The combined enterprise will include roughly 200 providers across nearly 100 sites, expand value-based primary and specialty care for NYC's Asian community, and pursue investments in clinical services, facilities and technology.
-
Parthenon Capital Invests in MRO Corporation
October 28, 2019
Healthcare Services
Parthenon Capital has completed a growth investment in MRO Corporation, acquiring a meaningful ownership stake and providing capital to support accelerated growth. MRO, a KLAS-rated leader in release of information (ROI) and PHI disclosure management based in Norristown, Pennsylvania, will use the funding to expand its capabilities and service offerings for healthcare providers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.